208 related articles for article (PubMed ID: 25563413)
21. Syndecan-1 and -4 influence Wnt signaling and cell migration in human breast cancers.
Pham SH; Pratt K; Okolicsanyi RK; Oikari LE; Yu C; Peall IW; Arif KT; Chalmers TA; Gyimesi M; Griffiths LR; Haupt LM
Biochimie; 2022 Jul; 198():60-75. PubMed ID: 35183674
[TBL] [Abstract][Full Text] [Related]
22. Loss of SDC1 Expression Is Associated with Poor Prognosis of Colorectal Cancer Patients in Northern China.
Li K; Li L; Wu X; Yu J; Ma H; Zhang R; Li Y; Wang W
Dis Markers; 2019; 2019():3768708. PubMed ID: 31182980
[TBL] [Abstract][Full Text] [Related]
23. Syndecan-1 Promotes Streptococcus pneumoniae Corneal Infection by Facilitating the Assembly of Adhesive Fibronectin Fibrils.
Jinno A; Hayashida A; Jenkinson HF; Park PW
mBio; 2020 Dec; 11(6):. PubMed ID: 33293379
[TBL] [Abstract][Full Text] [Related]
24. Follistatin-related protein 1 interacting partner of Syndecan-1 promotes an aggressive phenotype on Oral Squamous cell carcinoma (OSCC) models.
Zandonadi FS; Yokoo S; Granato DC; Rivera C; Macedo CCS; Soares CD; Carnielli CM; Domingues RR; Pauletti BA; Consonni SR; Colleta RD; Paes Leme AF
J Proteomics; 2022 Mar; 254():104474. PubMed ID: 34990821
[TBL] [Abstract][Full Text] [Related]
25. Compartmental Syndecan-1 (CD138) expression as a novel prognostic marker in triple-negative metaplastic breast cancer.
Ismail Y; Zakaria AS; Allam R; Götte M; Ibrahim SA; Hassan H
Pathol Res Pract; 2024 Jan; 253():154994. PubMed ID: 38071886
[TBL] [Abstract][Full Text] [Related]
26. Syndecan-1 expression by stromal fibroblasts promotes breast carcinoma growth in vivo and stimulates tumor angiogenesis.
Maeda T; Desouky J; Friedl A
Oncogene; 2006 Mar; 25(9):1408-12. PubMed ID: 16247452
[TBL] [Abstract][Full Text] [Related]
27. Host syndecan-1 promotes listeriosis by inhibiting intravascular neutrophil extracellular traps.
Aquino RS; Hayashida A; Park PW
PLoS Pathog; 2020 May; 16(5):e1008497. PubMed ID: 32453780
[TBL] [Abstract][Full Text] [Related]
28. Mammary gland development requires syndecan-1 to create a beta-catenin/TCF-responsive mammary epithelial subpopulation.
Liu BY; Kim YC; Leatherberry V; Cowin P; Alexander CM
Oncogene; 2003 Dec; 22(58):9243-53. PubMed ID: 14681683
[TBL] [Abstract][Full Text] [Related]
29. The niche factor syndecan-1 regulates the maintenance and proliferation of neural progenitor cells during mammalian cortical development.
Wang Q; Yang L; Alexander C; Temple S
PLoS One; 2012; 7(8):e42883. PubMed ID: 22936997
[TBL] [Abstract][Full Text] [Related]
30. Opposing roles of syndecan-1 and syndecan-2 in polyethyleneimine-mediated gene delivery.
Paris S; Burlacu A; Durocher Y
J Biol Chem; 2008 Mar; 283(12):7697-704. PubMed ID: 18216019
[TBL] [Abstract][Full Text] [Related]
31. The heparanase/syndecan-1 axis in cancer: mechanisms and therapies.
Ramani VC; Purushothaman A; Stewart MD; Thompson CA; Vlodavsky I; Au JL; Sanderson RD
FEBS J; 2013 May; 280(10):2294-306. PubMed ID: 23374281
[TBL] [Abstract][Full Text] [Related]
32. Syndecan-1 serves as the major receptor for attachment of hepatitis C virus to the surfaces of hepatocytes.
Shi Q; Jiang J; Luo G
J Virol; 2013 Jun; 87(12):6866-75. PubMed ID: 23576506
[TBL] [Abstract][Full Text] [Related]
33. Synstatin: a selective inhibitor of the syndecan-1-coupled IGF1R-αvβ3 integrin complex in tumorigenesis and angiogenesis.
Rapraeger AC
FEBS J; 2013 May; 280(10):2207-15. PubMed ID: 23375101
[TBL] [Abstract][Full Text] [Related]
34. Prognostic significance of syndecan-1 expression in squamous cell carcinoma of the tonsil.
Lee SH; Choi EJ; Kim MS; Park JW; Lee YS; Kim SY; Kang CS
Int J Clin Oncol; 2014 Apr; 19(2):247-53. PubMed ID: 23553620
[TBL] [Abstract][Full Text] [Related]
35. Relationship between SDC1 and cadherin signalling activation in cancer.
Liao S; Liu C; Zhu G; Wang K; Yang Y; Wang C
Pathol Res Pract; 2020 Jan; 216(1):152756. PubMed ID: 31810587
[TBL] [Abstract][Full Text] [Related]
36. Insights into the molecular roles of heparan sulfate proteoglycans (HSPGs-syndecans) in autocrine and paracrine growth factor signaling in the pathogenesis of Hodgkin's lymphoma.
Gharbaran R
Tumour Biol; 2016 Sep; 37(9):11573-11588. PubMed ID: 27317256
[TBL] [Abstract][Full Text] [Related]
37. Expression of syndecan-1 in oral cavity squamous cell carcinoma.
Woźniak M; Nahajowski M; Hnitecka S; Rutkowska M; Nowak M; Mitelsztet P; Szkudlarek D; Makuch S
J Histotechnol; 2021 Mar; 44(1):46-51. PubMed ID: 33357145
[TBL] [Abstract][Full Text] [Related]
38. Syndecan-1 and Its Expanding List of Contacts.
Stepp MA; Pal-Ghosh S; Tadvalkar G; Pajoohesh-Ganji A
Adv Wound Care (New Rochelle); 2015 Apr; 4(4):235-249. PubMed ID: 25945286
[No Abstract] [Full Text] [Related]
39. Syndecan-1 Mediates Sorting of Soluble Lipoprotein Lipase with Sphingomyelin-Rich Membrane in the Golgi Apparatus.
Sundberg EL; Deng Y; Burd CG
Dev Cell; 2019 Nov; 51(3):387-398.e4. PubMed ID: 31543446
[TBL] [Abstract][Full Text] [Related]
40. Syndecan-1 couples the insulin-like growth factor-1 receptor to inside-out integrin activation.
Beauvais DM; Rapraeger AC
J Cell Sci; 2010 Nov; 123(Pt 21):3796-807. PubMed ID: 20971705
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
